FDA 483 - ONY Biotech, Inc. - February 05, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
ONY Biotech, Inc., an API and sterile drug manufacturer in Amherst, NY, was cited for significant deficiencies in quality control and manufacturing processes. The inspection revealed failures to thoroughly investigate discrepancies and microbial excursions, inadequate procedures for preventing microbiological contamination of sterile products, and unauthorized changes to temperature monitoring without proper documentation. These issues indicate a lack of robust quality systems and control over critical manufacturing steps.
ID · 5f77d626-2462-4295-8c7e-65931d243887